K-numberK243025
Device nameUreteral Access Sheath
ApplicantSeplou (Zhuhai) Co., Ltd.
Product codeFED
Device classClass II
Decision dateJan 30, 2025
DecisionSubstantially Equivalent
Regulation876.1500
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Ureteral Access Sheath is a single-use medical device that establishes a conduit during endoscopic urological procedures, allowing passage of endoscopes and other instruments into the urinary tract. It is designed to facilitate treatment of urinary stones and other urinary diseases during minimally invasive endoscopic procedures.

Technological characteristics

The subject device differs from the predicate in three main ways: (1) material composition—uses PTFE+PEBAX+304 stainless steel with LDPE dilator versus predicate's PTFE+PA+stainless steel with PE dilator; (2) sheath length ranges 28–50 cm versus predicate's 13–55 cm; (3) structure—offers both tip-unbendable and tip-bendable variants with suction capability, versus predicate's simpler single-design approach. Both share the same ID range (10–14 Fr), hydrophilic coating, and EO sterilization.

Test standards cited

Biocompatibility testing per ISO 10993 series (cytotoxicity, irritation, sensitization, acute systemic toxicity, pyrogenicity); performance testing covering dimension, compatibility, fracture force, bending resistance, liquid leakage, and friction; sterilization validation per ISO 11135 and ISO 11737; shelf-life validation per ISO 11607, DIN 58953-6, and ASTM F2096, F88, F1886, F1929, D4169.

Substantial equivalence argument

Although the subject device differs in materials, length specifications, and structural design from the predicate, these differences do not raise new safety or effectiveness questions because: (1) both devices share identical regulatory classification, product code, and intended use for establishing ureteral access conduits; (2) all material differences have been validated through comprehensive biocompatibility and performance testing demonstrating safety; (3) the technological variations represent only design choices within established parameters and do not fundamentally alter the device's mechanism of action or clinical function.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →